Volpara Health Technologies (ASX.VHT), Finance News Network Investor Event, October 2017
PRESENTER
Email
Volpara Health Technologies
SLIDES
1. Volpara Health Technologies
2. Disclaimer
3. Volpara Health Technologies (“Volpara”, ASX:VHT)
4. Breast cancer screening using mammography (x-ray) – key to early detection
5. Volpara improves the quality & productivity of breast cancer screening
6. We sell direct in our main market, the USA, as of June 2016
7. Significant sales growth
8. Cash balance tracking as planned
9. Capital structure & share register: strong support from top shareholders
10. Resident radiology expert – Dr Monica Saini
11. Looking Ahead – Commercial milestones coming up
12. Investment summary
13. Appendix
14. Who are we? A reputable, influential Board
15. Who are we? An experienced, qualified management team
16. Intellectual property position
17. Software as a Service (SaaS) Business Model
18. VolparaDensity – automated, objective density scoring
19. Anatomy of an Enterprise deal
Volpara Health Technologies (ASX.VHT), Finance News Network Investor Event, October 2017
RESOURCES
1 / 19
ASX:VHT
Ralph Highnam, PhD (Oxford)
Chief Executive Officer
Volpara (VHT) Presentation
FNN Investor Event, October 2017
volparasolutions.com  |  NZ 2206998  |  ABRN 609 946 867
000000000000000000000000000000000000000000000000